发明名称 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
摘要 The invention provides isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 27875, 22025, 27420, 16319, 55092 and 10218 gene has been introduced or disrupted. The invention still further provides isolated 27875, 22025, 27420, 17906, 16319, 55092 or 10218 proteins, fusion proteins, antigenic peptides and anti-27875, 22025, 27420, 17906, 16319, 55092 or 10218 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
申请公布号 US7098015(B2) 申请公布日期 2006.08.29
申请号 US20030386414 申请日期 2003.03.11
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 KAPELLER-LIBERMANN, ROSANA;WHITE, DAVID;ROBISON, KEITH E;MACBETH, KYLE J.;CARROLL, JOSEPH M.;COOK, WILLIAM JAMES;MEYERS, RACHEL E.;CHUN, MIYOUNG;WILLIAMSON, MARK J.
分类号 C12N9/16;A61K38/00;C12N9/10;C12N9/64;C12N15/54;C12N15/62;C12N15/79;C12Q1/68;G01N33/569;G01N33/574;G01N33/576;G01N33/68 主分类号 C12N9/16
代理机构 代理人
主权项
地址